Cytoviva Inc is categorized under Optical Instruments and Lenses Manufacturers in Auburn, AL and active since 2006.
Cytoviva Inc was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Optical Instruments and Lenses Manufacturers business, which does work in the B2B market, and is classified as a Optical Instruments and Lenses Manufacturers, under code number 333314 by the NAICS.
If you are seeking more information, feel free to contact John O Lawrence at the company’s headquarters by writing to 570 Devall Drive # 301, Auburn, Alabama AL 36832 or by phoning (334) 749-0134. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Cytoviva Inc |
Contact Person: | John O Lawrence |
Address: | 570 Devall Drive # 301, Auburn, Alabama 36832 |
Phone Number: | (334) 749-0134 |
Website Address: | aetostech.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2006 |
Location Type: | Headquarters |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Optical Instruments and Lenses Manufacturers |
SIC Code: | 3827 |
NAICS Code: | 333314 |
Share This Business: |
Cytoviva Inc was started in 2006 to provide professional Optical Instruments and Lenses Manufacturers under the SIC code 3827 and NAICS code 333314. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact John O Lawrence for inquiries that concern Cytoviva Inc by calling the company number (334) 749-0134, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Cytoviva Inc can be found at the coordinates 32.585732,-85.494023 as well as the street address 570 Devall Drive # 301 in Auburn, Alabama 36832.
For its online presence, you may visit Cytoviva Inc’s website at aetostech.com and engage with its social media outlets through on Twitter and on Facebook.